These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15504218)

  • 21. [New perspectives in the treatment of viral hepatitis C: pegylated interferon alpha].
    Alric L; Cacoub P
    Rev Med Interne; 2001 Oct; 22(10):922-5. PubMed ID: 11695314
    [No Abstract]   [Full Text] [Related]  

  • 22. Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C.
    Koksal I
    J Gastroenterol Hepatol; 2006 Mar; 21(3):491-4. PubMed ID: 16638088
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?
    Vogel M; Page E; Nelson M; Rockstroh JK
    J HIV Ther; 2009 Mar; 14(1):8-12. PubMed ID: 19731559
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic hepatitis C in hemodialysis patients.
    Casanovas T
    Hepatology; 2009 Jun; 49(6):2126; author reply 2126. PubMed ID: 19475688
    [No Abstract]   [Full Text] [Related]  

  • 25. Viral hepatitis in renal transplantation.
    Vathsala A
    Transplant Proc; 1999; 31(1-2):337-9. PubMed ID: 10083133
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis and solid organ transplantation.
    Pol S; Samuel D; Cadranel J; Legendre C; Bismuth H; Bréchot C; Kreis H
    Transplant Proc; 2000 Mar; 32(2):454-7. PubMed ID: 10715478
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
    Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
    J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Care of patients with hepatitis C and HIV co-infection.
    Soriano V; Puoti M; Sulkowski M; Mauss S; Cacoub P; Cargnel A; Dieterich D; Hatzakis A; Rockstroh J
    AIDS; 2004 Jan; 18(1):1-12. PubMed ID: 15090824
    [No Abstract]   [Full Text] [Related]  

  • 29. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha.
    Sherman M; Marinos G; Sedarati F
    Ann Intern Med; 2001 Nov; 135(10):927-8. PubMed ID: 11712887
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of chronic Hepatitis C in 2008].
    Niederau C; Kaden T
    MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV/viral hepatitis coinfection: the Immunology Center experience.
    Taylor LE
    Med Health R I; 2009 Jul; 92(7):234-6. PubMed ID: 19685638
    [No Abstract]   [Full Text] [Related]  

  • 32. Sexually transmitted reinfection with a new hepatitis C genotype during pegylated interferon and ribavirin therapy.
    den Hollander JG; Rijnders BJ; van Doornum GJ; van der Ende ME
    AIDS; 2005 Mar; 19(6):639-40. PubMed ID: 15802989
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute hepatitis C infection: epidemiological and clinical aspects, and efficacy of interferon therapy].
    Luchi S; Ricciardi L; Meini M; Fiorini I; de Gennaro M; Moneta S; Bosco G; Scasso A
    Infez Med; 2007 Jun; 15(2):93-8. PubMed ID: 17598995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
    Thompson AJ; Muir AJ; Sulkowski MS; Patel K; Tillmann HL; Clark PJ; Naggie S; Fellay J; Ge D; McCarthy JJ; Goldstein DB; McHutchison JG
    Hepatology; 2010 Dec; 52(6):2243-4. PubMed ID: 20890887
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiological and clinical study for hepatitis C virus infection].
    Hayashi J; Furusyo N
    Fukuoka Igaku Zasshi; 2010 Mar; 101(3):46-52. PubMed ID: 20653197
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C: Enhancing treatment for hepatitis C among drug users.
    Grebely J; Dore GJ
    Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):11-3. PubMed ID: 21119610
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiviral treatment in liver cirrhosis due to hepatitis C virus].
    Martínez-Bauer E; Forns X
    Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin.
    Al-Hamoudi W; Mohamed H; Abaalkhail F; Kamel Y; Al-Masri N; Allam N; Alqahtani S; Al-Sofayan M; Khalaf H; Al-Sebayel M; Al-Jedai A; Abdo A
    Dig Dis Sci; 2011 Jun; 56(6):1848-52. PubMed ID: 21221800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.
    Oton E; Barcena R; Moreno-Planas JM; Cuervas-Mons V; Moreno-Zamora A; Barrios C; Garcia-Garzon S; Moreno A; Boullosa-Graña E; Rubio-Gonzalez EE; Garcia-Gonzalez M; Blesa C; Mateos ML
    Am J Transplant; 2006 Oct; 6(10):2348-55. PubMed ID: 16869810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.